{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:04:00Z","timestamp":1779890640304,"version":"3.53.1"},"reference-count":51,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Chronic respiratory diseases (CRDs) represent a significant global mortality burden, largely driven by viral-triggered exacerbations. In the elderly, susceptibility to viral pathogens is critically linked to the \u201cinterferon gap\u201d\u2014a kinetic delay in innate antiviral signaling resulting from immunosenescence and Th2-skewed inflammaging. While traditional vaccines provide pathogen-specific protection, their efficacy is often compromised by age-related immune hyporesponsiveness and antigenic drift. This perspective paper proposes a dual-phase, virus-agnostic immunomodulatory platform designed to restore mucosal immune competence and provide a rapid-response intervention for incipient exacerbations. Rather than acting as a pathogen-specific vaccine, the platform serves as a comprehensive host immune-rejuvenation engine and cellular adjuvant platform. The platform consists of two integrated stages: Allopriming and Alloantigen Inhalation Recall (AIR). Allopriming utilizes AlloStim\u00ae (activated, allogeneic Th1 cells) to leverage the evolutionarily conserved allo-rejection response, establishing a lung mucosal reservoir of allo-specific Th1 tissue-resident memory cells (Trm). Building on previously published Phase I\/II data showing that Allopriming reverses biomarkers of immunosenescence and sustains durable heterologous antiviral responsiveness, the AIR strategy is introduced as a patient-administered rescue mechanism for frail CRD patients. AIR is designed to activate pre-positioned Trm cells at the earliest onset of symptoms, inducing a high-magnitude IFN-\u03b3 surge in the lung mucosa. By bridging the senescent \u201cinterferon gap\u201d with the rapid effector kinetics of Trm activation, this approach represents a novel paradigm toward reconstituting youthful-like antiviral mucosal immunity to both enhance vaccine efficacy in the elderly and protect against both seasonal pathogens and emerging viral triggers (\u201cDisease X\u201d) of CRD. Future randomized studies in long-term care settings are planned to evaluate clinical outcomes in high-risk populations.<\/jats:p>","DOI":"10.3390\/vaccines14060475","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:31:56Z","timestamp":1779885116000},"page":"475","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Virus-Agnostic Cellular Immunomodulatory Platform for Chronic Respiratory Disease: Restoring Immune Competence and Mitigating Exacerbations in the Elderly"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9342-9337","authenticated-orcid":false,"given":"Michael","family":"Har-Noy","sequence":"first","affiliation":[{"name":"Immunovative Therapies, Ltd., Jerusalem 9610203, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S2213-2600(24)00339-4","article-title":"The global burden of COPD: Epidemiology and effect of prevention strategies","volume":"13","author":"Celli","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pccm.2025.02.005","article-title":"Global, regional, and national burden of asthma from 1990 to 2021: A systematic analysis of the global burden of disease study 2021","volume":"3","author":"Mao","year":"2025","journal-title":"Chin. Med. J. Pulm. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"103051","DOI":"10.1016\/j.eclinm.2024.103051","article-title":"Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: A systematic analysis of the global burden of disease study 2021","volume":"80","author":"Yuan","year":"2025","journal-title":"eClinicalMedicine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/infdis\/jis739","article-title":"Increased severity of 2009 pandemic influenza A virus subtype H1N1 infection in alveolar type II cells from patients with pulmonary fibrosis","volume":"207","author":"Fujino","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kurai, D., Saraya, T., Ishii, H., and Takizawa, H. (2013). Virus-induced exacerbations in asthma and COPD. Front. Microbiol., 4.","DOI":"10.3389\/fmicb.2013.00293"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1189\/jlb.0703315","article-title":"Host defense function of the airway epithelium in health and disease: Clinical background","volume":"75","author":"Message","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"ref_7","first-page":"77","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"31","author":"Falsey","year":"2005","journal-title":"Exp. Lung Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e71882","DOI":"10.1002\/hsr2.71882","article-title":"The Impact of COVID-19 on Obstructive Pulmonary Diseases: A Narrative Review of Long-Term Consequences and Vaccination Strategies","volume":"9","author":"Dalfardi","year":"2026","journal-title":"Health Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1159\/000544919","article-title":"Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS\/ETS, SIMIT, SIP\/IRS, and SItI","volume":"104","author":"Micheletto","year":"2025","journal-title":"Respiration"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/S2213-2600(25)00432-1","article-title":"GOLD COPD report: 2026 update","volume":"14","author":"Venkatesan","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Su, Z., Cheshmehzangi, A., McDonnell, D., da Veiga, C.P., and Xiang, Y.T. (2022). Mind the \u201cVaccine Fatigue\u201d. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.839433"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2477300","DOI":"10.1080\/07853890.2025.2477300","article-title":"Age-related changes in the immune system and challenges for the development of age-specific vaccines","volume":"57","author":"Doherty","year":"2025","journal-title":"Ann. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4062\/biomolther.2025.222","article-title":"Immunosenescence in Human Disease: Mechanistic Insights and Therapeutic Opportunities","volume":"34","author":"Kim","year":"2026","journal-title":"Biomol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Muller, L., and Di Benedetto, S. (2025). Immunosenescence and inflammaging: Mechanisms and modulation through diet and lifestyle. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1708280"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.2002.01736.x","article-title":"Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?","volume":"127","author":"Sandmand","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Papp, G., Szab\u00f3, K., J\u00e1mbor, I., Mile, M., Berki, A.R., Arany, A.C., Makra, G., Szodoray, P., Csiki, Z., and Balogh, L. (2021). Regular Exercise May Restore Certain Age-Related Alterations of Adaptive Immunity and Rebalance Immune Regulation. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.639308"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1084\/jem.20041901","article-title":"Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus","volume":"201","author":"Wark","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm1462","article-title":"Role of deficient type III interferon-\u03bb production in asthma exacerbations","volume":"12","author":"Contoli","year":"2006","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4049\/jimmunol.2200533","article-title":"An Innate Checkpoint Determines Immune Dysregulation and Immunopathology during Pulmonary Murine Coronavirus Infection","volume":"210","author":"Grabherr","year":"2023","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ito, K. (2026). Harnessing innate immunity to prevent viral exacerbations: Current strategies and future directions for chronic inflammatory lung disease management. Expert Rev. Respir. Med., 1\u20134.","DOI":"10.1080\/17476348.2026.2618293"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12931-024-02854-7","article-title":"Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPD","volume":"25","author":"Monk","year":"2024","journal-title":"Respir. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cytogfr.2022.01.001","article-title":"Current utilization of interferon alpha for the treatment of coronavirus disease 2019: A comprehensive review","volume":"63","author":"Lu","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJMp2118468","article-title":"Universal Coronavirus Vaccines\u2014An Urgent Need","volume":"386","author":"Morens","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.immuni.2025.11.003","article-title":"Human lung CD8+ tissue-resident memory T cell-derived interferon-\u03b3 orchestrates subset-specific antiviral programming in airway epithelial cells","volume":"58","author":"Mattingly","year":"2025","journal-title":"Immunity"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.mehy.2007.10.008","article-title":"The anti-tumor effect of allogeneic bone marrow\/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?","volume":"70","author":"Slavin","year":"2008","journal-title":"Med. Hypotheses"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.leukres.2008.08.017","article-title":"Allogeneic CD3\/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia\/lymphoma","volume":"33","author":"Zeira","year":"2009","journal-title":"Leuk. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/bmj.2.5352.269","article-title":"Tissue Transplantation: A New Approach to the \u201cTyping\u201d Problem","volume":"2","author":"Brent","year":"1963","journal-title":"Br. Med. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1172\/JCI105168","article-title":"Studies of Lymphocyte Transfer Reactions in Hodgkin\u2019s Disease","volume":"44","author":"Aisenberg","year":"1965","journal-title":"J. Clin. Investig."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","article-title":"Hallmarks of T cell aging","volume":"22","author":"Mittelbrunn","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Singh, H., and Agrawal, D.K. (2022). Therapeutic Potential of Targeting the HMGB1\/RAGE Axis in Inflammatory Diseases. Molecules, 27.","DOI":"10.3390\/molecules27217311"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 Deficiency Reveals a Critical Role for CD8\u03b1 + Dendritic Cells in Cytotoxic T Cell Immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.4049\/jimmunol.1700382","article-title":"CXCR3 Signaling Is Required for Restricted Homing of Parenteral Tuberculosis Vaccine\u2013Induced T Cells to Both the Lung Parenchyma and Airway","volume":"199","author":"Jeyanathan","year":"2017","journal-title":"J. Immunol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Pejoski, D., Ballester, M., Auderset, F., Vono, M., Christensen, D., Andersen, P., Lambert, P.H., and Siegrist, C.A. (2019). Site-Specific DC Surface Signatures Influence CD4+ T Cell Co-stimulation and Lung-Homing. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.01650"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41385-019-0224-7","article-title":"Pulmonary monocytes interact with effector T cells in the lung tissue to drive TRM differentiation following viral infection","volume":"13","author":"Dunbar","year":"2020","journal-title":"Mucosal Immunol."},{"key":"ref_36","first-page":"141","article-title":"The Allogeneic Effect on Immune Responses: Model for Regulatory Influences of T Lymphocytes on the Immune System","volume":"12","author":"Katz","year":"1972","journal-title":"Transplant. Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0952-7915(00)00191-6","article-title":"Danger signals: SOS to the immune system","volume":"13","author":"Gallucci","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1038\/s41467-025-60448-3","article-title":"Neoantigens combined with in situ cancer vaccination induce personalized immunity and reshape the tumor microenvironment","volume":"16","author":"Feng","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri.2016.147","article-title":"Programmed cell death as a defence against infection","volume":"17","author":"Jorgensen","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Rodrigues, M.C., Morais, J.A.V., Ganassin, R., Oliveira, G.R.T., Costa, F.C., Morais, A.A.C., Silveira, A.P., Silva, V.C.M., Longo, J.P.F., and Muehlmann, L.A. (2022). An Overview on Immunogenic Cell Death in Cancer Biology and Therapy. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081564"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Lee, S.M., and Kim, E.H. (2025). The role of cell death pathways in respiratory viral infection and vaccination: Two sides of the same coin. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1650960"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Dutt, T.S., Krause, R., Hertz, D., Henao-Tamayo, M., Leslie, A., and Schneider, B. (2026). B cells and iBALT in TB immunity & pathogenesis. Front. Immunol., 17.","DOI":"10.3389\/fimmu.2026.1743572"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Liu, C., Yang, X., Paoli-Bruno, J., Sikes, D., Marin-Ruiz, A.V., Thomas, N., Shane, R., and Har-Noy, M. (2025). Allo-Priming Reverses Immunosenescence and May Restore Broad Respiratory Viral Protection and Vaccine Responsiveness to the Elderly: Results of a Phase I\/II Clinical Trial. Vaccines, 13.","DOI":"10.20944\/preprints202503.2194.v1"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1016\/j.celrep.2019.11.103","article-title":"Bystander Activation of Pulmonary Trm Cells Attenuates the Severity of Bacterial Pneumonia by Enhancing Neutrophil Recruitment","volume":"29","author":"Ge","year":"2019","journal-title":"Cell Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41232-024-00333-6","article-title":"Tissue-resident memory T cells: Decoding intra-organ diversity with a gut perspective","volume":"44","author":"Murakami","year":"2024","journal-title":"Inflamm. Regen."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.immuni.2024.06.017","article-title":"Resident memory T cells and cancer","volume":"57","author":"Gavil","year":"2024","journal-title":"Immunity"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1021\/acssynbio.9b00433","article-title":"Unlocking Applications of Cell-Free Biotechnology through Enhanced Shelf Life and Productivity of E. coli Extracts","volume":"9","author":"Gregorio","year":"2020","journal-title":"ACS Synth. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2146\/ajhp100452","article-title":"Inhaler device selection: Special considerations in elderly patients with chronic obstructive pulmonary disease","volume":"68","author":"Barrons","year":"2011","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1084\/jem.20160938","article-title":"Specific niches for lung-resident memory CD8+ T cells at the site of tissue regeneration enable CD69-independent maintenance","volume":"213","author":"Takamura","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Hernandez-Ruiz, Y.G., Lopatynsky-Reyes, E.Z., Ulloa-Gutierrez, R., Avila-Ag\u00fcero, M.L., Rodriguez-Morales, A.J., Basa, J.E., Nikiema, F.W., and Chacon-Cruz, E. (2025). 100-Day Mission for Future Pandemic Vaccines, Viewed Through the Lens of Low- and Middle-Income Countries (LMICs). Vaccines, 13.","DOI":"10.20944\/preprints202506.0591.v1"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e1764","DOI":"10.1016\/S2214-109X(24)00286-9","article-title":"Impact of the 100 days mission for vaccines on COVID-19: A mathematical modelling study","volume":"12","author":"Barnsley","year":"2024","journal-title":"Lancet Glob. Health"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/6\/475\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:11:44Z","timestamp":1779887504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/6\/475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":51,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["vaccines14060475"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14060475","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]}}}